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Introduction
Migraine affects 3%–10.6% of the population and results
in substantial morbidity and economic burden [1]. The
impact of migraine may reach far beyond the episodic
pain associated with headache attacks. From the patients’
perspective, the effects are dramatic and migraine-related
disability has both physical and emotional dimensions.
The effect on perceived quality of life may persist
between migraine headaches because of their inherent
unpredictability. As a public health concern with enor-
mous potential impact on society, a better understanding
of the effect of migraine on quality of life may improve
the allocation of appropriate resources and research
directed towards migraine.
Health-related quality of life (HRQOL) refers to the
patient’s perception of the overall effect of illness and its
treatment on his or her ability to live a fulfilling life [2].
As a concept it closely resembles the World Health
Organization’s definition of health itself [3]. Traditional
measures of clinical efficacy such as reduction in
headache frequency, duration or severity fail to fully
assess the patient’s perspective of living with migraine.
Over 50 years ago, Lembcke expressed a holistic
approach when he wrote: “the best measure of quality is
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Abstract The objective was to
determine the impact of migraine
on health-related quality of life
(HRQOL) among Canadians.
Analysis was based on the public
use microdata set of the Canadian
Community Health Survey (CCHS),
limited to those aged ≥15 residing
in Manitoba. HRQOL was mea-
sured using the SF-36 survey,
which covers 8 health concepts.
Multivariate linear regression was
used to model each SF-36 scale
against age, gender, education,
income, migraine status and pres-
ence of mood or anxiety disorders.
Of the 7236 CCHS respondents,
9.7% reported a diagnosis of
migraine. Reported migraine pre-
dicted statistically significant
(p<0.0001) lower HRQOL in all
SF-36 domains with profound
impairment of physical role, bodily
pain and general health. Those
reporting a mood disorder scored
significantly lower in all domains
with pronounced effects on emo-
tional role, social functioning and
general health. Reported anxiety
disorder was associated with lower
HRQOL in 6/8 domains. Canadians
with migraine report significant
impairment in HRQOL compared to
the general population, independent
of psychiatric morbidity.
Keywords Headache • Migraine •
Health-related quality of life • SF-36
Received: 29 June 2006
Accepted in revised form: 19 July 2006
Published online: 10 December 2006
44
not how well or how frequently a medical service is given,
but how closely the result approaches the fundamental
objectives of prolonging life, relieving distress, restoring
function and preventing disability” [4]. There has been a
recent renewal of interest regarding the impact of
migraine on HRQOL. HRQOL measurement tools com-
municate the impact of illness on the patient’s well-being,
providing unique insight into the evaluation and manage-
ment of migraine. Previous studies have indicated signifi-
cant reductions in HRQOL among subjects with migraine
[5–10]. Despite the episodic nature of migraine, HRQOL
has been shown to be comparable to living with chronic
diseases such as diabetes and arthritis [5]. However, the
majority of these studies have been conducted in clinic-
based settings, which potentially select for more severe or
more disabling migraines.
It is well known that migraine is strongly associated
with anxiety and depression. A recent Canadian-based
population study confirmed the frequent co-occurrence of
migraine and major depression [11]. However, little is
known about the impact of anxiety and depression on
migraine-related disability and quality of life. Lantéri-
Minet et al. [12] found increased migraine disability and
greater impairment in HRQOL when migraine was associ-
ated with anxiety and depression. The complex interaction
of such characteristic psychiatric disorders with migraine
subjects’ well-being and functional status is poorly under-
stood and under-recognised.
In this study we compare HRQOL using the SF-36
among Canadians reporting migraine with the general
population in the province of Manitoba, correcting for the
impact of mental health.
Materials and methods
To assess HRQOL, we used the Medical Outcomes Study 36-
Item Short Form (SF-36), which is a well established measure of
HRQOL with excellent reliability and validity [13]. It is consid-
ered a generic measure of HRQOL because the categories of
functional status and well-being are not age-, disease- or treat-
ment-specific [13]. The SF-36 covers 8 health concepts related
to functional status, well being and overall evaluation of health
by asking subjects to self-rate 36 items reflecting these health
domains (Table 1). All domains are scored on a scale of 0 to 100,
with 100 indicating the best possible health state [13]. The SF-
36 also includes two summary scores: one for physical health
and another for mental health. Normative data for the SF-36
health survey is available for age group, gender and country.
The Canadian Community Health Survey (CCHS) is a cross-
sectional survey that collects information related to health status,
health care utilisation and health determinants for the Canadian
population. A stratified cluster sample design is used to obtain
information on Canadians aged 12 years or older living in pri-
vate dwellings in the ten provinces and the three territories,
exclusive of persons living on First Nations Reserves or Crown
lands, residents of institutions, full-time members of the
Canadian Armed Forces and residents of certain remote regions.
Information is collected every 2 years [14, 15].
Our analysis was based on the public use microdata set of the
Canadian Community Health Survey, Cycle 2.1 (2003) [16].
Within this survey, there are question sequences addressed to all
respondents, and sections that are addressed to specific sub-pop-
ulations, generally to residents of specific provinces or health
districts. All respondents were asked, “Do you have migraine
headaches?” SF-36 data were available for all respondents resid-
ing in the province of Manitoba. All Manitoba residents had
been asked “Do you have a mood disorder such as depression,
bipolar disorder, mania or dysthymia?” and “Do you have an
anxiety disorder such as a phobia, obsessive-compulsive disor-
der or a panic disorder?” These questions could be validated
against other specific mental health data such as medication use,
visits with mental health professional and the depression scale
within other sub-populations in the same survey.
The data were analysed using Systat v9.0 [17]. Weights were
recoded to reflect the sample size (an average weight of 1). As
there have been previous reports of the association of migraine
with the SF-36 scores and known correlation between variables
(for example education and household income), we patterned our
analysis on these previous reports using multivariate linear
regression with similar variables, namely age (15–79 years in 5-
Table 1 Description of the SF-36 Health Survey
SF-36 health domain Number of items Definition
Physical functioning 10 Capacity to perform a variety of physical activities
Role disability due to physical problems 14 Extent to which physical health interferes with usual daily activities
Bodily pain 12 Extent of bodily pain in the past 4 weeks
General health 15 Overall ratings of health in general
Vitality 14 General energy, tiredness in past 4 weeks
Social functioning 12 Extent to which health interferes with normal social activities
Role disability due to emotional problems 13 Extent to which emotional problems interfere with usual daily activities
Mental health 15 General mood or affect, including depression, anxiety and positive 
well-being in the past 4 weeks
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year increments, >80 years), gender, education (less than sec-
ondary, secondary graduate, some post-secondary, post-sec-
ondary graduate) and household income (no income, CDN$
15 000–29 999, 30 000–49 999, 50 000–79 999, 80 000+). As the
stratification and clustering involved in the sample design is
only partially incorporated by the provided weights in the public
use datasets, the underlying sample variances were still likely to
be underestimated. Because of this, and the application of mul-
tiple statistical tests, we chose 0.0005 as a threshold alpha for
statistical tests involving discrete factors within multivariate
regression analysis of the SF-36 scales. We limited our analysis
to respondents aged 15 through >80 years. The validation data of
the self-reported mood and anxiety disorders are presented as
odds ratios. All analyses were performed within the parameters
outlined for analysis of Statistics Canada microdata files.
Results
There were a total of 7243 respondents from Manitoba. Data
were missing on migraine status for 0.1% (n=7) and these
respondents were excluded from the analysis. Data were
missing on marital status for 0.5%, education 1.9%, income
18%, mood disorder 0.2% and anxiety disorder 0.2%.
Of the remaining 7236 respondents, 699 (9.7%; 95%
CI: 8.9–10.5) reported migraine headaches, with a gender
distribution of 79.2% female. In the non-migraine group,
47.9% were female (p=0.001). There were no significant
differences in marital status, education levels or income
bracket in migraineurs vs. the normative Manitoba data
(Table 2). The migraine group reported higher frequencies
of both mood disorders (11.4% vs. 4.1%) and anxiety dis-
orders (7.1% vs. 2.8%) (p<0.001).
A comparison of SF-36 health scores for migraineurs
vs. the normative Manitoba data is presented in Figure 1.
In a multivariate analysis, reported migraine diagnosis
predicted statistically lower HRQOL scores across all 8
health domains (p<0.0001) and lower summary measures
of both physical and mental health (Table 3). In 6 of 8
HRQOL domains, reductions in scores were greater than 5
points, which is recognised as a clinically significant
reduction in both univariate (Fig. 1) and multivariate
analysis (Table 3) [13]. Migraine was associated with the
most dramatic impairment in the domains of physical role,
bodily pain and general health perceptions, while mental
health scores were least affected.
The presence of a mood disorder dramatically
decreased all 8 HRQOL scores (p<0.0001) with large
reductions in scores ranging from 5.4 to 22.3. Mood dis-
orders were associated with profound impairment in the
domains of emotional role, social functioning and general
mental health. Reporting an anxiety disorder also signifi-
cantly impaired 6 of 8 HRQOL domains, with less impact
on physical functioning and vitality. Anxiety disorder had
most pronounced effects on physical role, emotional role
and general mental health.
Table 2 Demographic characteristics and comorbidities of migraine vs. non-migraine populations
All Migraine Non-migraine
Age (years), mean (quartiles) 43 (29.5, 57) 44 (27, 43)* 43 (29.5, 58)
Gender, female, % 50.9 79.2* 47.9
Marital status
Married, % 56.5 53.1* 56.8
Common-law, % 5.2 9.2* 4.8
Widowed, separated, divorced, % 12.0 8.5* 12.3
Single, % 26.4 29.2* 26.1
Education
Less than secondary, % 27.5 22.5* 28.0
Secondary graduate, % 21.6 24.2* 21.3
Other post-secondary, % 8.4 8.5* 8.4
Post-secondary graduate, % 42.5 44.7* 42.3
Income
<15 000, % 6.1 6.6* 6.0
15 000–29 999, % 15.1 14.1* 15.2
30 000–49 999, % 24.8 27.4* 24.6
50 000–79 999, % 27.2 24.7* 27.5
>80 000, % 26.8 27.2* 26.7
Mood disorder, % 4.8 11.4* 4.1
Anxiety disorder, % 3.2 7.1* 2.8
*p<0.001
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SF-36 scores were generally lower for females, as pre-
viously reported in Canadian normative data [18]. This
effect was primarily in physical functioning and vitality
scores. Increasing age categories significantly lowered all
SF-36 domains, with the exception of vitality. There was
a decline in scores with each 5-year age category.
Increased education levels predicted higher physical func-
tioning and general health perception scores. Advances in
household income level also had a positive effect on all
domains except role disability due to emotional problems
and a mild effect on the bodily pain scale (Table 3).
The validity of a self-reported mood disorder was
established by correlation with tranquilliser use (OR 8.9,
p<0.0001), antidepressant use (OR 56.8, p<0.0001) and
contact with a mental health professional (OR 23.3,
p<0.0001). Those reporting a mood disorder also scored
higher on the depression scale, with an average score of
2.88; where a score of 3 represents a 50% likelihood of
depression [19]. Similarly, the validity of self-reported
anxiety disorder was established by correlation with tran-
quilliser use (OR 9.9, p<0.0001), antidepressant use (OR
19.9, p<0.0001) and contact with a mental health profes-
Fig. 1 SF-36 scores for subjects
with migraine vs. the general popu-
lation in Manitoba
PF, physical functioning; RP, role-
physical; BP, bodily pain; GH, gen-
eral health; VT, vitality; SF, social
functioning; RE, role-emotional;
MH, mental health
PF RP BP GH VT SF RE MH
Norm 89.3 84.3 79.8 75.9 65.4 90.9 92.3 83.2
Migraine 85.2 70.0 64.2 65.3 55.3 84.7 84.4 77.2
Table 3 Results of multivariate linear regression analyses to test migraine and mood/anxiety disorders as predictors of each SF-36 scale score
Physical Role- Bodily General Vitality Social Role- Mental Summary Summary 
functioning physical pain health functioning emotional health physical mental 
health health
Constant 96.4** 89.2** 85.7** 77.3** 66.8** 90.2** 91.9** 81.2** 56.5** 55.4**
Age category -2.17** -1.07** -0.98** -1.00** -0.18** -0.30** 0.46** 0.41** -0.28** 0.80**
Gender -3.62** -2.28** -1.67** -0.24*v -4.14** -1.06** -0.91** -1.40** -1.68** -1.21**
(declines with 
female gender)
Education 1.38** 0.35** 0.37** 1.19** 0.12** 0.34** 0.58** 0.05** 0.43** 0**
Household income 1.99** 1.56** 0.75** 1.47** 1.10** 1.53** -0.21** 0.71** -0.07** -0.51**
Migraine -5.79** -13.64** -17.1** -11.43** -9.34** -4.46** -5.17** -4.29** -6.67** -2.70**
Mood disorder -5.41** -12.88** -6.46** -9.89** -12.16** -16.14** -22.28** -15.0** -1.37*v -8.01**
Anxiety disorder -2.92** -11.65** -8.37** -6.35** -3.81** -8.49** -11.00** -8.63** -2.30** -4.53**
*p<0.0001; **p<0.00001
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sional (OR 11.1, p<0.0001). Of those reporting a mood
disorder, one third also report on anxiety disorder.
Discussion
In this large population-based study we observed substan-
tial HRQOL morbidity with migraine across all SF-36
health domains. The presence of a mood and/or an anxiety
disorder also negatively affected HRQOL, but the effect
of migraine was independent, remaining highly signifi-
cant after correcting for mental health disorders.
Several previous studies have shown lower HRQOL
for migraineurs. Monzon and Lainez [6] showed lower
SF-36 scores for migraine patients compared to healthy
controls across all 8 domains. A population-based study
using the RAND-36 (a Dutch translation of the SF-36)
similarly demonstrated decreased scores on all 8 health
domains for migraineurs [7]. We have observed a compa-
rable trend with statistically significant reductions in all 8
subscales for subjects with migraine compared to their
non-migraine counterparts. Migraine was associated with
clinically significant reductions in 6 of 8 subscales, while
mood disorders were associated with clinically significant
declines in all HRQOL domains. To put these reductions
in perspective, a drop of 20 points on the mental health
scale is consistent with a tripling in the probability of sui-
cidal ideation and doubling of the probability of depres-
sion [13]. Such a reduction in HRQOL could be easily
observed with combined impact of migraine and mood
disorder, for example.
It is well recognised that psychiatric comorbidity may
confound studies of migraine HRQOL. Therefore, it is
critical to account for the potentially confounding effects
of mood and/or anxiety disorders that also negatively
impact HRQOL. As expected, we observed high comor-
bidity for migraine and mood/anxiety disorders. Mood
and anxiety disorders were associated with significant
decrements in HRQOL. Our results are compatible with a
previous US/UK population-based study, which showed
migraine and depression to each have a significant and
independent negative impact on HRQOL [8]. Our multi-
variate models demonstrate that subjects with migraine
have reduced HRQOL independent of comorbid depres-
sion or anxiety.
Migraine had the greatest negative impact in role
physical, bodily pain and general health perceptions. A
similar trend was observed by Osterhaus et al. [5], who
conducted the SF-36 survey in a migraine population
recruited from general practitioners, newspapers and
referrals, and showed the greatest reductions in the bodily
pain and role physical scales among migraineurs. Role
physical and bodily pain have substantial validity as mea-
sures of physical health [13]. Mood disorders had the most
impact on social functioning, role emotional and general
health domains, while anxiety had the greatest impact on
role physical, role emotional and general mental health.
According to Ware, mental health is best evaluated by the
mental health, role emotional and social functioning
domains of the SF-36, while the general health measure
encompasses both physical and mental health [13].
Migraine and mood/anxiety disorders tend to affect differ-
ent HRQOL domains and therefore the presence of both
disorders may have a profound effect on quality of life.
Although HRQOL instruments like the SF-36 provide
insight into the impact of migraine on functional status
and well-being, they are potentially affected by other indi-
vidual factors (e.g., finances, relationships, accommoda-
tion, recreational activities). Because HRQOL is a global
measure of well-being, advances in education and income
level are, not unexpectedly, associated with improved
quality of life. In our study, however, there were no sig-
nificant differences in income or level of education among
migraineurs vs. non-migraineurs. This is in contrast to a
previous multi-national study, where 39% of migraine
patients reported a negative impact on job or school per-
formance and 16% reported that migraine prevented them
from achieving career goals [20]. However, this study was
limited to women between 18 and 35 years old with
migraine and based on subjective responses regarding
impact of migraine on job, education and career goals,
while our study assesses more objective measures of
income and education level.
The diagnosis of migraine in our patients was based on
a diagnosis by a health practitioner rather than on specif-
ic criteria. To our knowledge, the question about migraine
used in the CCHS has not been validated against an exter-
nal standard. A similar question, “Have you ever had
migraine?”, has been validated against a diagnostic tele-
phone interview administered by physicians trained in
headache diagnosis, with a sensitivity of 75.8% (95% CI:
72.4–79.0) and specificity of 86.4% (95% CI: 84.3–88.3)
[21]. In an Internet-based study of subjects reporting
migraine, after reviewing subjects’ narrative description
of headache qualities, a neurologist assigned a high or
moderate probability of migraine to 97%, and to 97%
using IHS criteria [22]. These studies suggest that the
question used in the CCHS may be valid. Despite the self-
reporting of migraine diagnosis in our study, the preva-
lence and gender distribution are compatible with pub-
lished Canadian data [23].
Our study was based on a large cross-sectional, provin-
cially representative population with a remarkably com-
plete dataset. The representativeness of the sample and
high participation rate are superior to studies done within a
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clinical setting as there is little potential for bias. Such
provincially representative datasets are designed to guide
health policy. Supplementary analyses of these same
datasets have the potential to answer clinically relevant,
important questions. One drawback to these supplementary
analyses is that relevant and pertinent questions may not
have been asked of the respondents within the original sur-
vey. We were unable to assess the effects of migraine
severity or frequency on HRQOL as this data was not col-
lected in the CCHS. One previous population-based study
has examined the impact of migraine frequency, duration
and severity on HRQOL and identified frequency as an
important predictor of mental and physical HRQOL [8].
In this population-based study, Canadians with
migraine report clinically and statistically significant
impairment in HRQOL compared to those without
migraine. This effect is independent of psychiatric
comorbidities such as depression and anxiety. Nearly
10% of the Canadian population report a diagnosis of
migraine with the potential for substantial HRQOL bur-
den. Incorporation of HRQOL instruments into the
assessment and management of migraine will undoubt-
edly become an essential part of migraine evaluation and
treatment. Given the frequently observed detrimental
impact on physical components of the SF-36 among
migraineurs, these HRQOL dimensions may play an
integral part in optimising therapeutic goals for individ-
uals with migraine. Efforts at migraine management
should include lifestyle strategies aimed at improving
well-being for those with migraine.
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